Pepsin as a causal agent of inflammation during nonacidic reflux

Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 5, 2009, Pages 559-563

  Samuels, Tina L ^a   Johnston, Nikki ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCL1 CHEMOKINE; CHEMOKINE RECEPTOR CCR6; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL14 CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; CYTOKINE RECEPTOR; EOTAXIN; EOTAXIN 2; EOTAXIN 3; INTERLEUKIN 1; INTERLEUKIN 1 F 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 5; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 4; PEPSIN A; PROTEIN BCL 6; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HYPOPHARYNX; IN VITRO STUDY; INCUBATION TIME; INFLAMMATION; LABORATORY; PH MEASUREMENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CYTOKINES; EPITHELIAL CELLS; ESOPHAGITIS, PEPTIC; HUMANS; HYPOPHARYNX; INFLAMMATION; PEPSIN A; RECEPTORS, CYTOKINE;

EID: 70350501815     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.08.022     Document Type: Article

References (20)

1. Postma G.N., and Halum S.L. Laryngeal and pharyngeal complications of gastroesophageal reflux disease. Available at: GI Motility Online. http://www.nature.com/gimo/contents/pt1/full/gimo46.html Accessed July 11, 2009
2. Fitzgerald R.C., Onwuegbusi B.A., Bajaj-Elliott M., et al. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 50 (2002) 451-459
3. Avidan B., Sonnenberg A., Schnell T.G., et al. Acid reflux is a poor predictor for severity of erosive reflux esophagitis. Dig Dis Sci 47 (2002) 2565-2573
4. Yoshida N., Uchiyama K., Kuroda M., et al. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand J Gastroenterol 39 (2004) 816-822
5. Isomoto H., Inoue K., and Kohno S. Interleukin-8 levels in esophageal mucosa and long-term clinical outcome of patients with reflux esophagitis. Scand J Gastroenterol 42 (2007) 410-411
6. Thibeault S.L., Smith M.E., Peterson K., et al. Gene expression changes of inflammatory mediators in posterior laryngitis due to laryngopharyngeal reflux and evolution with PPI treatment: a preliminary study. Laryngoscope 117 (2007) 2050-2056
7. Oelschlager B.K., Quiroga E., Isch J.A., et al. Gastroesophageal and pharyngeal reflux detection using impedance and 24-hour pH monitoring in asymptomatic subjects: defining the normal environment. J Gastrointest Surg 10 (2006) 54-62
8. Sharma N., Agrawal A., Freeman J., et al. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol 6 (2008) 521-524
9. Koufman J.A. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101 (1991) 1-78
10. Johnston N., Wells C.W., Blumin J.H., et al. Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol 116 (2007) 934-938
11. Johnston N., Wells C.W., Samuels T.L., et al. Pepsin in non-acidic refluxate can damage hypopharyngeal epithelial cells. Ann Otol Rhinol Laryngol 118 (2009) 677-685
12. Samuels T.L., Handler E., Syring M.L., et al. Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. Ann Otol Rhinol Laryngol 117 (2008) 688-695
13. Johnston N., Dettmar P.W., Bishwokarma B., et al. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope 117 (2007) 1036-1039
14. Isomoto H., Wang A., Mizuta Y., et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol 98 (2003) 551-556
15. Yoshida N., Kuroda M., Uchiyama K., et al. Microarray analysis of transcriptome in patients with nonerosive reflux disease. Gastroenterology 128 (2005) A523
16. Naito Y., Kuroda M., Uchiyama K., et al. Inflammatory response of esophageal epithelium in combined-type esophagitis in rats: a transcriptome analysis. Int J Mol Med 18 (2006) 821-828
17. Rees L.E., Pazmany L., Gutowska-Owsiak D., et al. The mucosal immune response to laryngopharyngeal reflux. Am J Respir Crit Care Med 177 (2008) 1187-1193
18. McDonald K.G., McDonough J.S., Wang C., et al. CC chemokine receptor 6 expression by B lymphocytes is essential for the development of isolated lymphoid follicles. Am J Pathol 170 (2007) 1229-1240
19. Kanazawa Y., Isomoto H., Wen C.Y., et al. Impact of endoscopically minimal involvement on IL-8 mRNA expression in esophageal mucosa of patients with non-erosive reflux disease. World J Gastroenterol 9 (2003) 2801-2804
20. Crapko M., Kerschner J.E., Syring M., et al. Role of extra-esophageal reflux in chronic otitis media with effusion. Laryngoscope 117 (2007) 1419-1423